Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil
PLOS ONE
RESEARCH ARTICLE
Modelling the effect of compliance with WHO
salt recommendations on cardiovascular
disease mortality and costs in Brazil
Eduardo Augusto Fernandes Nilson ID1*, Adriana Blanco Metlzer2, Marie-Eve Labonté3,
Patrı́cia Constante Jaime4
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
1 Department of Global Health and Sustainability, School of Public Health, University of Sao Paulo, Sao
Paulo, São Paulo, Brazil, 2 Costa Rican Institute of Research and Training in Nutrition and Health
(INCIENSA), San Jose, Costa Rica, 3 Institute of Nutrition and Functional Foods, Laval University, Québec
City, Quebec, Canada, 4 Department of Global Health and Sustainability, School of Public Health, University
of Sao Paulo, Sao Paulo, São Paulo, Brazil
*
Abstract
OPEN ACCESS
Introduction
Citation: Nilson EAF, Metlzer AB, Labonté M-E,
Jaime PC (2020) Modelling the effect of
compliance with WHO salt recommendations on
cardiovascular disease mortality and costs in
Brazil. PLoS ONE 15(7): e0235514. https://doi.org/
10.1371/journal.pone.0235514
Cardiovascular diseases (CVDs) represent the main cause of death among non-communicable diseases (NCDs) in Brazil, and they have a high economic impact on health systems.
Most populations around the world, including Brazilians, consume excessive sodium, which
increases blood pressure and the risk of CVDs.
Editor: Tatsuo Shimosawa, International University
of Health and Welfare, School of Medicine, JAPAN
Objective
Received: February 28, 2020
Accepted: June 16, 2020
Published: July 9, 2020
Copyright: © 2020 Nilson et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Computerized raw
data files and documentation from the surveys are
publicly available from the Brazilian Institute of
Geography and Statistics – IBGE (ftp://ftp.ibge.gov.
br/PNS/2013/microdados/pns_2013_microdados_
2017_03_23.zip, https://www.ibge.gov.br/
estatisticas/sociais/populacao/9109-projecao-dapopulacao.html?=&t=downloads) and complete
tables on mortality and costs of morbidity are
publicly available from the Department of
Informatics of the (http://tabnet.datasus.gov.br/cgi/
deftohtm.exe?sim/cnv/obt10uf.def, http://tabnet.
To model the estimated deaths and costs associated with CVDs, which are mediated by
increased blood pressure attributable to excessive sodium consumption in adults from the
perspective of the Brazilian public health system in 2017.
Methods
We employed two macrosimulation methods, using top-down approaches and based on the
same relative risks. The models estimated the mortality and costs-of-illness attributable to
excessive sodium intake and mediated by hypertension for adults aged over 30 years in
2017. Direct healthcare cost data (inpatient care, outpatient care and medications) were
extracted from the Ministry of Health information systems and official records.
Results
In 2017, an estimated 46,651 deaths from CVDs could have been prevented if the average
sodium consumption had been reduced to 2 g/day in Brazil. Premature deaths related to
excessive sodium consumption caused 575,172 Years of Life Lost and US$ 752.7 million in
productivity losses to the economy. In the same year, the National Health System’s costs of
hospitalizations, outpatient care and medication for hypertension attributable to excessive
sodium consumption totaled US$192.1 million. The main causes of death and costs
PLOS ONE | https://doi.org/10.1371/journal.pone.0235514 July 9, 2020
1 / 15
PLOS ONE
Modelling salt recommendations on cardiovascular disease mortality and costs in Brazil
datasus.gov.br/cgi/deftohtm.exe?sih/cnv/niuf.def,
http://www2.datasus.gov.br/DATASUS/index.php?
area=0901&item=1&acao=22&pad=31655).
Details on the modelling inputs are available in the
Supplementary Materials.
associated with CVDs were coronary heart disease and stroke, followed by hypertensive
disease, heart failure and aortic aneurysm.
Funding: This article was possible due to an
unrestricted research grant from the IDRC
(International Research Development Centre of
Canada), project #108167, “Scaling Up and
Evaluating Salt Reduction Policies and Programs in
Latin American Countries". The founding sponsors
had no role in the design of the study; in the
collection, analyses, or interpretation of data; in the
writing of the manuscript; and in the decision to
publish the results.
Excessive sodium consumption is estimated to account for 15% of deaths by CVDs and to
14% of the inpatient and outpatient costs associated with CVD. It also has high societal
costs in terms of premature deaths. CVDs are a leading cause of disease and economic burden on the global, regional and country levels. As a largely preventable and treatable conditions, CVDs require the strengthening of cost-effective policies, supported by evidence,
including modeling studies, to reduce the costs relating to illness borne by the Brazilian public health system and society.
Conclusion
Competing interests: The authors have declared
that no competing interests exist.
Introduction
Non-communicable diseases (NCDs) are the main cause of death and disability globally and in
Brazil. According to the Global Burden of Disease studies, in 2017, 11 million deaths and 255
million Disability Adjusted Years (DALYs) were attributable to dietary risk factors worldwide.
A high intake of sodium is considered the primary diet-related risk factor (being responsible
for 3 million deaths and 70 million DALYs), because of its strong association with NCDs, such
as cardiovascular diseases (ischemic heart disease, stroke, and hypertension) [1].
Cardiovascular diseases are one of the leading causes of global mortality and morbidity,
and they also represent a major economic burden on health care systems in terms of the direct
(e.g., medical consultations, hospitalizations, rehabilitation services, and drugs) and indirect
(e.g., losses of productivity due to premature mortality and short- or long-term disability)
costs associated with mortality and morbidity.
The costs of CVDs, as NCDs, are likely to continue to grow due to inadequate diets, an
increase in obesity and the aging of societies, so it is very important to address the burden of
these diseases in terms of mortality, morbidity and the costs to health systems and society. In
addition, economic studies can provide evidence to support CVD prevention programs, which
are very cost-effective measures, compared to the costs associated with treating CVD-related
conditions [2].
In recent decades, the development of many health and economic modelling methodologies, involving both macro and microsimulations and static and dynamic analysis has
improved and supported policy decisions by analyzing the potential impact and cost-effectiveness of health interv (...truncated)